Burning Rock Biotech Ltd. (BNR)
US Market

Burning Rock Biotech (BNR) Stock Price & Analysis


BNR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.70 - $4.24
Previous Close$2.42
Average Volume (3M)59.63K
Market Cap
Enterprise Value-$626.08M
Total Cash (Recent Filing)¥925.27M
Total Debt (Recent Filing)¥50.79M
Price to Earnings (P/E)-1.9
Aug 30, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.26
Shares Outstanding82,330,000
10 Day Avg. Volume49,694
30 Day Avg. Volume59,634
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)0.19
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside267.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Burning Rock Biotech Ltd.’s price range in the past 12 months?
Burning Rock Biotech Ltd. lowest stock price was $1.70 and its highest was $4.24 in the past 12 months.
    What is Burning Rock Biotech Ltd.’s market cap?
    Currently, no data Available
    When is Burning Rock Biotech Ltd.’s upcoming earnings report date?
    Burning Rock Biotech Ltd.’s upcoming earnings report date is Aug 30, 2023 which is in 88 days.
      How were Burning Rock Biotech Ltd.’s earnings last quarter?
      Burning Rock Biotech Ltd. released its earnings results on May 30, 2023. The company reported -$0.255 earnings per share for the quarter, missing the consensus estimate of -$0.196 by -$0.059.
        Is Burning Rock Biotech Ltd. overvalued?
        According to Wall Street analysts Burning Rock Biotech Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Burning Rock Biotech Ltd. pay dividends?
          Burning Rock Biotech Ltd. does not currently pay dividends.
          What is Burning Rock Biotech Ltd.’s EPS estimate?
          Burning Rock Biotech Ltd.’s EPS estimate is -$0.19.
            How many shares outstanding does Burning Rock Biotech Ltd. have?
            Burning Rock Biotech Ltd. has 82,327,410 shares outstanding.
              What happened to Burning Rock Biotech Ltd.’s price movement after its last earnings report?
              Burning Rock Biotech Ltd. reported an EPS of -$0.255 in its last earnings report, missing expectations of -$0.196. Following the earnings report the stock price went up 2.632%.
                Which hedge fund is a major shareholder of Burning Rock Biotech Ltd.?
                Among the largest hedge funds holding Burning Rock Biotech Ltd.’s share is Bridgewater Associates, LP. It holds Burning Rock Biotech Ltd.’s shares valued at 182K.


                  Burning Rock Biotech Stock Smart Score

                  The Burning Rock Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Burning Rock Biotech Ltd.

                  Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and LungPlasma. The company has developed various cancer detection products , involving tumor targeting, oncomitant diagnosis of immune drugs, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress and detection of tumor sensitivity.


                  Top 5 ETFs holding BNR

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold BNR. The ETFs are listed according to market value of BNR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Sinovac Biotech
                  Gracell Biotechnologies
                  Genetron Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis